Results 21 to 30 of about 59,185 (303)
Herpes Zoster Vaccines [PDF]
The Journal of Infectious Diseases, 2021 Abstract Herpes zoster (HZ) affects approximately 1 in 3 persons in their lifetime, and the risk of HZ increases with increasing age. The most common, debilitating complication of HZ is the chronic neuropathic pain of postherpetic neuralgia (PHN).Harbecke, Ruth, Cohen, Jeffrey I, Oxman, Michael N +2 moreopenaire +2 more sourcesImmunogenicity and Safety of the Recombinant Adjuvanted Herpes Zoster Vaccine in Patients with Chronic Lymphocytic Leukemia and Multiple Myeloma. [PDF]
Vaccines (Basel)Diamantopoulos PT, Kontandreopoulou CN, Stafylidis C, Vlachopoulou D, Smilakou S, Patsialos I, Syriopoulou S, Gkikas A, Athanasopoulos EN, Vogiatzakis A, Panousi E, Kyriakakis G, Anastasopoulou A, Mantzourani M, Labropoulou V. +14 moreeuropepmc +3 more sourcesHerpes zoster after COVID vaccination [PDF]
International Journal of Infectious Diseases, 2021 COVID-19 presents in various ways, but mainly as a pulmonary disease (Marzano, 2020). Skin manifestations have been reported, including reactivation of the varicella-zoster virus (Marzano, 2020). Our case report describes two adults developing herpes zoster after vaccination with tozinameran (the Pfizer-BioNTech COVID-19 mRNA vaccine). A possible cause C.S. van Dam, I. Lede, J. Schaar, M. Al-Dulaimy, R. Rösken, M. Smits +5 moreopenaire +4 more sourcesAwareness and uptake of herpes zoster vaccine among patients with diabetes mellitus in the Aseer Region, Saudi Arabia: A cross-sectional study. [PDF]
Medicine (Baltimore)Alamri A, Althaqafi A, Salawati R, Asiri R, Aldugman M, Al Saleh M, AlAsmari B, AlBraik M, Ghazy RM, Ghazy RM. +9 moreeuropepmc +2 more sourcesLong-term Protection Against Herpes Zoster by the Adjuvanted Recombinant Zoster Vaccine: Interim Efficacy, Immunogenicity, and Safety Results up to 10 Years After Initial Vaccination
Open Forum Infectious Diseases, 2022 Approximately 10 years after vaccination with the recombinant zoster vaccine (RZV), an interim analysis of this follow-up study of the ZOE-50/70 trials demonstrated that efficacy against herpes zoster remained high.A. Strezova, J. Díez-Domingo, Kamal Al Shawafi, J. Tinoco, Meng Shi, P. Pirrotta, A. Mwakingwe-Omari, Michael Anitta Charles Eugene Jose-Fernando Piero Elisabet Adams Ahonen Andrews Athan BarbaGómez Barbanti Bar, M. Adams, Anitta Ahonen, C. Andrews, E. Athan, Jose-Fernando BarbaGómez, P. Barbanti, Elisabeth Barberan, A. Baty, N. Bengtsson, J. Berger-Roscher, Katarina Berndtsson Blom, J. Beytout, Loïc Boucher, C. Boutry, Alain Boye, François Brault, Laurie Breger, Carles Brotons Cuixart, Covadonga Caso, Christine Cerna, Huey‐Shinn Cheng, H. Cheong, E. Choo, C. Cunha, A. Cunningham, D. Curiac, Benoit Daguzan, Antje Dahmen, S. Datta, M. Desole, Emmanuel Di Paolo, M. Dionne, P. Dítě, J. Dutz, J. Earl, Tamara Eckermann, W. Ellison, J. Eremenko, Meral Esen, Takashi Eto, Xavier Farrés Fabré, C. Farrington, Murdo Ferguson, P. Ferrand, M. Finneran, David Francyk, Marsha Freedman, George Freeman, Antônio Tarcísio Freire, P. Gal, Jean-Sébastien Gauthier, B. Gerlach, W. Ghesquière, I. Gorfinkel, Christine Grigat, J. Grosskopf, Monika Hamann, Pascal Hanrion, P. Hartley, Andrew Hastie, Ken Heaton, Agnes Himpel-Boenninghoff, T. Horácek, D. S. Hui, Yieng Huong, Shinn-Jang Hwang, G. Icardi, Gabriele Illies, J. Irimajiri, W. Jacob, A. Jambrecina, T. Avelino-Silva, George Kalema, Hyo Youl Kim, C. Klein, U. Kleinecke, H. Koenig, Satu Kokko, P. Kosina, Susan V. Koski, P. Koskinen, Maximilian Kropp, Rie Kuroki, Outi Laajalahti, P. Lachance, Jacob Lee, Jin-Soo Lee, P. Levins, R. Lipetz, Bo Liu, Chiu-Shong Liu, Martin Lundvall, Luci Magimaiseelan, Mary Beth Manning, Jukka Markkula, Frederick H. Martin, Pyrene Martínez Piera, D. McNally, S. Mcneil, G. Migliorino, B. Moeckesch, Stephan Morscher, Michael Mueller, Abul Kashem Mohammad Munir, C. M. de Oliveira, Kenjiro Nakamura, Sílvia Narejos Pérez, Yuji Naritomi, P. Nault, José Luiz Neto, C. López, Hiroaki Ogata, Å. Olsson, P. Paavola, D. Park, Jan Patrick, K. Pauksens, Mercè Pérez Vera, L. Peltonen, Georg Plassmann, A. Põder, Terry L. Poling, Carol Pretswell, Samir Purnell-Mullick, George Raad, M. Redmond, Philippe Remaud, E. Riffer, Patrick Robert, Alex Rodríguez Badia, María Luisa Rodríguez de la Pinta, L. Rombo, R. Rosen, Shari Rozen, Dominique Saillard, B. Salaun, J. S. Berglund, J. Sauter, A. Schaefer, Isabelle Schenkenberger, Juergen Schmidt, Bernhard Schmitt, C. Schubert, A. Schuind, T. Schwarz, Ilkka Seppa, Edmund Kwok Yiu Sha, G. Shockey, Sylvia Shoffner, Elina Sirnela-Rif, T. Staniscia, H. Sueki, Shin-ichi Suzuki, D. Taminau, G. Tellier, Manuel Terns Riera, Azhar Toma, Nicole Toursarkissian, M. Turner, Benita Ukkonen, Anna Vilella Morató, Juergen Wachter, Brian Webster, Karl Wilhelm, Jonathan Wilson, Wilfred W Yeo, Chong-Jen Yu, T. Zahaf, I. Zahharova, C. Zerbini +177 moresemanticscholar +1 more sourceThe Adjuvanted Recombinant Zoster Vaccine Confers Long-Term Protection Against Herpes Zoster: Interim Results of an Extension Study of the Pivotal Phase 3 Clinical Trials ZOE-50 and ZOE-70
Clinical Infectious Diseases, 2021 Background This ongoing follow-up study evaluated the persistence of efficacy and immune responses for 6 additional years in adults vaccinated with the glycoprotein E (gE)-based adjuvanted recombinant zoster vaccine (RZV) at age ≥50 years in 2 pivotal ...C. Boutry, Andrew Hastie, J. Díez-Domingo, J. Tinoco, Chong-Jen Yu, C. Andrews, J. Beytout, Covadonga Caso, Huey‐Shinn Cheng, H. Cheong, E. Choo, Dan Curiac, E. Di Paolo, M. Dionne, Tamara Eckermann, Meral Esen, Murdo Ferguson, W. Ghesquière, Shinn-Jang Hwang, T. Avelino-Silva, P. Kosina, C. Liu, Jukka Markkula, B. Moeckesch, Cláudia Murta de Oliveira, D. Park, K. Pauksens, P. Pirrotta, Georg Plassmann, Carol Pretswell, L. Rombo, B. Salaun, J. Sanmartin Berglund, Isabelle Schenkenberger, T. Schwarz, Meng Shi, Benita Ukkonen, T. Zahaf, C. Zerbini, A. Schuind, A. Cunningham, Michael Anitta Eugene Jose-Fernando Piero Elisabeth Alain Adams Ahonen Athan Barba-Gómez Barbanti Barberan B, M. Adams, Anitta Ahonen, E. Athan, J. Barba-Gómez, P. Barbanti, Elisabeth Barberan, A. Baty, N. Bengtsson, J. Berger-Roscher, Katarina Berndtsson Blom, Loïc Boucher, Alain Boye, François Brault, Laurie Breger, Carles Brotons Cuixart, Christine Cerna, C. Cunha, Benoit Daguzan, Antje Dahmen, S. Datta, Maria Giuseppina Desole, P. Dítě, J. Dutz, J. Earl, W. Ellison, J. Eremenko, Takashi Eto, Xavier Farrés Fabré, C. Farrington, Pierre André Ferrand, M. Finneran, David Francyk, Marsha Freedman, George Freeman, P. Gal, Jean-Sébastien Gauthier, B. Gerlach, I. Gorfinkel, Christine Grigat, J. Grosskopf, Monika Hamann, Pascal Hanrion, P. Hartley, Ken Heaton, Agnes Himpel-Boenninghoff, T. Horácek, David Shu Cheong Hui, Yieng Huong, G. Icardi, Gabriele Illies, J. Irimajiri, A. Jambrecina, Hyo Youl Kim, C. Klein, U. Kleinecke, H. Koenig, Satu Kokko, P. Koskinen, Maximilian Kropp, Rie Kuroki, Outi Laajalahti, P. Lachance, Jacob Lee, Jin-Soo Lee, P. Levins, R. Lipetz, Bo Liu, Martin Lundvall, Mary Beth Manning, Frederick H. Martin, P. Martínez Piera, D. McNally, S. Mcneil, G. Migliorino, Stephan Morscher, M. Mueller, Abul Kashem Munir, Kenjiro Nakamura, S. Narejos Pérez, Yuji Naritomi, P. Nault, José Luiz Neto, Concepción Núñez López, Hiroaki Ogata, Å. Olsson, P. Paavola, Jan Patrick, Mercè Pérez Vera, A. Põder, Terry L. Poling, Samir Purnell-Mullick, George Raad, M. Redmond, Philippe Remaud, E. Riffer, Patrick Robert, Alex Rodríguez Badia, M. Luisa Rodríguez de la Pinta, Robert Rosen, Shari Rozen, Dominique Saillard, J. Sauter, A. Schaefer, Juergen Schmidt, Bernhard Schmitt, C. Schubert, Ilkka Seppa, Edmund Kwok Yiu Sha, G. Shockey, Sylvia Shoffner, Elina Sirnela-Rif, T. Staniscia, H. Sueki, Shin-ichi Suzuki, D. Taminau, G. Tellier, M. Terns Riera, Azhar Toma, Nicole Toursarkissian, M. Turner, A. Vilella Morató, Juergen Wachter, Brian Webster, Karl Wilhelm, Jonathan Wilson, Wilfred W Yeo, I. Zahharova +168 moresemanticscholar +1 more sourceWillingness to vaccinate against herpes zoster in Chinese urban population: a mixed-methods study
BMJ Open, 2023 Objective Although the herpes zoster vaccine has been available in mainland China since June 2020, residents’ knowledge of herpes zoster and the herpes zoster vaccine is poor, and vaccination rates are low, especially among the elderly, who are at high ...Ping He, Beibei Yuan, Dawei Zhu, Ming Wang, Yanshang Wang, Mingzheng Hu, Chao Long, Yiqi Xia, Weiying Zhao +8 moredoaj +1 more sourceKnowledge, attitudes, and practices of the United Arab Emirates population towards Herpes Zoster vaccination: A cross-sectional study
Human Vaccines & Immunotherapeutics, 2022 Herpes Zoster is a viral infection that occurs due to reactivation of the Varicella Zoster virus. A vaccine has been approved for adults aged 50 and above for the prevention of Herpes Zoster and its complications.Teba Al-Khalidi, Radwa Genidy, Muna Almutawa, Mohammad Mustafa, Saryia Adra, Najem Edeen Kanawati, Thureya Binashour, Hiba Jawdat Barqawi +7 moredoaj +1 more source
